{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:13:38Z","timestamp":1788430418726,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Psykiatri affektiva, Sahlgrenska Universitetssjukhuset, VGR"},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To study the prospects for lithium treated patients who develop end stage renal disease (ESRD) and the role of renal replacement therapy (RRT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective analysis of survival, somatic comorbidity, lithium treatment and eligibility for renal replacement therapy in adult patients with at least one eGFR\u2009&lt;\u200930\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>. Subjects were selected from our laboratory database (s-Lithium and s-creatinine) from 1980 to 2017.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>620 (14%) of 4396 patients with a lithium history had at least one measurement of eGFR\u2009&lt;\u200930\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>. 302 (49%) patients had a transient decrease in renal function with subsequent improvement, 135 (22%) patients died with acute renal failure, while 153 (25%) developed chronic kidney disease stage 4 (CKD4) and 33 (5%) required RRT. RRT-treated patients represent only a fraction of the total ESRD population. Median survival time from the debut of CKD4 was 13.9\u00a0years in patients\u2009&lt;\u200965\u00a0years and 4.4\u00a0years in older patients.<\/jats:p>\n            <jats:p>100 of the 153 patients with CKD4 continued lithium treatment. There was no significant difference in survival after the debut of CKD4 between the patients who stopped lithium treatment and those who continued.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A measurement of eGFR\u2009&lt;\u200930\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> reflects a significant loss of renal function. In half of the patients it was due to a transient functional disturbance without long-term consequences. A quarter of patients had acute renal failure and died within days while the remaining quarter progressed to CKD4. Despite irreversible renal damage, patient survival can be counted in several years after debut of renal insufficiency with appropriate care including RRT. As the treating psychiatrist, it is important to consult with nephrology when renal function starts to deteriorate, to optimise somatic treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40345-025-00372-z","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T19:13:12Z","timestamp":1739560392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospects for lithium treated patients with severe renal impairment"],"prefix":"10.1186","volume":"13","author":[{"given":"Harald","family":"Aiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ola","family":"Attman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Golic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Ramsauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinn","family":"Steingrimsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Svedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"2","key":"372_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0269881113516202","volume":"28","author":"H Aiff","year":"2014","unstructured":"Aiff H, Attman PO, Aurell M, Bendz H, Sch\u00f6n S, Svedlund J. The impact of modern treatment principles may have eliminated lithium-induced renal failure. J Psychopharmacol. 2014;28(2):151\u20134.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"372_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0269881115573808","volume":"29","author":"H Aiff","year":"2015","unstructured":"Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Sch\u00f6n S. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol Oxf Engl. 2015;29(5):608\u201314.","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"372_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jad.2018.09.044","volume":"243","author":"H Aiff","year":"2019","unstructured":"Aiff H, Attman PO, Ramsauer B, Schon S, Svedlund J. Cardiovascular comorbidity increases the risk for renal failure during prophylactic lithium treatment. J Affect Disord. 2019;243:416\u201320.","journal-title":"J Affect Disord"},{"issue":"9","key":"372_CR4","first-page":"1250","volume":"9","author":"H Bendz","year":"1994","unstructured":"Bendz H, Aurell M, Balldin J, Mathe AA, Sjodin I. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transpl. 1994;9(9):1250\u20134.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"372_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/00365513.2011.557086","volume":"71","author":"J Bj\u00f6rk","year":"2011","unstructured":"Bj\u00f6rk J, Grubb A, Sterner G, Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malmo Study cohort. Scand J Clin Lab Invest Maj. 2011;71(3):232\u20139.","journal-title":"Scand J Clin Lab Invest Maj"},{"issue":"7","key":"372_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22056","volume":"6","author":"A Bosi","year":"2023","unstructured":"Bosi A, Clase CM, Ceriani L, Sj\u00f6lander A, Fu EL, Runesson B. Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden. JAMA Netw Open. 2023;6(7): e2322056.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"372_CR7","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/ndt\/gfaa095","volume":"36","author":"NC Chesnaye","year":"2021","unstructured":"Chesnaye NC, Dekker FW, Evans M, Caskey FJ, Torino C, Postorino M. Renal function decline in older men and women with advanced chronic kidney disease-results from the EQUAL study. Nephrol Dial Transpl. 2021;36(9):1656\u201363.","journal-title":"Nephrol Dial Transpl"},{"key":"372_CR8","unstructured":"Davidson-Pilon C. Lifelines, survival analysis in Python. Zenodo; 2024. https:\/\/zenodo.org\/records\/10456828. Accessed 17 Apr 2024."},{"key":"372_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12882-018-1101-4","volume":"19","author":"J Davis","year":"2018","unstructured":"Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrol. 2018;19:305.","journal-title":"BMC Nephrol"},{"issue":"10","key":"372_CR10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1177\/0269881118780014","volume":"32","author":"M Golic","year":"2018","unstructured":"Golic M, Aiff H, Attman PO, Ramsauer B, Sch\u00f6n S, Svedlund J. Compliance with the safety guidelines for long-term lithium treatment in Sweden. J Psychopharmacol Oxf Engl. 2018;32(10):1104\u20139.","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"6","key":"372_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bdi.13178","volume":"24","author":"R Hoekstra","year":"2022","unstructured":"Hoekstra R, Lekkerkerker MN, Kuijper TM, Bosch TM, van Alphen AM. Renal function after withdrawal of lithium. Bipolar Disord. 2022;24(6):667\u201370.","journal-title":"Bipolar Disord"},{"key":"372_CR12","unstructured":"Raybaut P. Spyder IDE [Internet]. The spyder development team; 2024. Available from: https:\/\/www.spyder-ide.org."},{"key":"372_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jamapsychiatry.2015.1834","volume":"72","author":"LV Kessing","year":"2015","unstructured":"Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study. JAMA Psychiat. 2015;72:1182\u201391.","journal-title":"JAMA Psychiat"},{"issue":"6","key":"372_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/acps.12820","volume":"136","author":"LV Kessing","year":"2017","unstructured":"Kessing LV, Feldt-Rasmussen B, Andersen PK, Gerds TA, Licht RW. Continuation of lithium after a diagnosis of chronic kidney disease. Acta Psychiatr Scand. 2017;136(6):615\u201322.","journal-title":"Acta Psychiatr Scand"},{"issue":"84","key":"372_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.euroneuro.2024.04.009","volume":"24","author":"LV Kessing","year":"2024","unstructured":"Kessing LV, Knudsen MB, Rytgaard HCW, Torp-Pedersen C, Berk M. Lithium versus anticonvulsants and the risk of physical disorders\u2014results from a comprehensive long-term nation-wide population-based study emulating a target trial. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2024;24(84):48\u201356.","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"issue":"1","key":"372_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12882-017-0473-1","volume":"18","author":"UH Lundstr\u00f6m","year":"2017","unstructured":"Lundstr\u00f6m UH, Gasparini A, Bellocco R, Qureshi AR, Carrero JJ, Evans M. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study. BMC Nephrol. 2017;18(1):59.","journal-title":"BMC Nephrol"},{"issue":"10265","key":"372_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","volume":"396","author":"RS McIntyre","year":"2020","unstructured":"McIntyre RS, Berk M, Brietzke E, Goldstein BI, L\u00f3pez-Jaramillo C, Kessing LV. Bipolar disorders. Lancet Lond Engl. 2020;396(10265):1841\u201356.","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"372_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ackd.2013.05.004","volume":"20","author":"J Neugarten","year":"2013","unstructured":"Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20(5):390\u20135.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"372_CR19","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.ekir.2022.07.165","volume":"7","author":"CL Ramspek","year":"2022","unstructured":"Ramspek CL, Boekee R, Evans M, Heimburger O, Snead CM, Caskey FJ. Predicting kidney failure, cardiovascular disease and death in advanced CKD patients. Kidney Int Rep. 2022;7(10):2230\u201341.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"372_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/gps.3841","volume":"28","author":"S Rej","year":"2013","unstructured":"Rej S, Abitbol R, Looper K, Segal M. Chronic renal failure in lithium-using geriatric patients: effects of lithium continuation versus discontinuation\u2013a 60-month retrospective study. Int J Geriatr Psychiatry. 2013;28(5):450\u20133.","journal-title":"Int J Geriatr Psychiatry"},{"key":"372_CR21","unstructured":"SNR. Svenskt Njurregister \u00c5rsrapport 2023."},{"key":"372_CR22","unstructured":"The Swedish National Board of Health and Welfare. National Cause of Death Register. 2024. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-cause-of-death--register\/."},{"key":"372_CR23","unstructured":"The Swedish National Board of Health and Welfare. The Swedish Prescribed Drug Register. 2024 [cited 2024-11-01].  \/https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/statistikamnen\/lakemedel\/. Accessed 01 Nov 2024."},{"issue":"4","key":"372_CR24","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117-314.","journal-title":"Kidney Int"},{"key":"372_CR25","unstructured":"Swedish Death Index. Sveriges Sl\u00e4ktforskarf\u00f6rbund. 2023. https:\/\/www.rotter.se\/sw-death-index"},{"issue":"7","key":"372_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ekir.2022.04.008","volume":"7","author":"N Tabibzadeh","year":"2022","unstructured":"Tabibzadeh N, Vidal-Petiot E, Cheddani L, Haymann JP, Lefevre G, Etain B. Chronic lithium therapy and urine-concentrating ability in individuals with bipolar disorder: association between daily dose and resistance to vasopressin and polyuria. Kidney Int Rep. 2022;7(7):1557\u201364.","journal-title":"Kidney Int Rep"},{"key":"372_CR27","unstructured":"The pandas development team. pandas-dev\/pandas: Pandas. Zenodo; 2024. https:\/\/zenodo.org\/records\/10697587. Accessed 17 Apr 2024."},{"issue":"4","key":"372_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11255-009-9604-3","volume":"41","author":"AH Zhang","year":"2009","unstructured":"Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol. 2009;41(4):977\u201382.","journal-title":"Int Urol Nephrol"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-025-00372-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40345-025-00372-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-025-00372-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T19:13:18Z","timestamp":1739560398000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-025-00372-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1186\/s40345-025-00372-z","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}